New antibody combo could shield kids from rabies after bites
NCT ID NCT07327307
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 232 children under 18 who received a new antibody injection (zamerovimab and mazorelvimab) plus the rabies vaccine after a severe animal bite. Researchers track whether the children stay rabies-free for up to one year. The goal is to see if this combination prevents rabies effectively in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Zamerovimab and Mazorelvimab injection (antibodies) plus rabies vaccine
What this could lead to
If successful, this could confirm a new antibody treatment that, combined with the vaccine, prevents rabies after severe bites in children.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. Rabies is rare, so proving effectiveness is challenging.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES POST-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Nanhua Hospital, University of South China
RECRUITINGHengyang, Hunan, China
Contact
Contact
-
Hunan Provincial People's Hospital
RECRUITINGChangsha, Hunan, China
Contact
Contact
-
Jiangxi Provincial Chest Hospital
RECRUITINGNanchang, Jiangxi, China
Contact
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Shenzhen second people's hospital
RECRUITINGShenzhen, Guangdong, China
Contact Phone: •••-•••-••••
Contact
-
The University of Hong Kong - Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, China
Contact
Contact